Molecular testing is transforming post-transplant care, reducing the need for invasive biopsies and personalizing medication regimens to lower the risk of infection and other downstream side effects, according to a presentation by Jeffrey Teuteberg, MD, this morning at the Annual Meeting and Scientific Sessions of the International Society of Heart and Lung Transplantation (ISHLT).
This article was originally published on MedicalXpress.com
As a health and wellness enthusiast, I have always been interested in the role of supplements in promoting optimal health. In Canada, there are many supplements available on the market, each with different benefits and […]
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
What Are Boundaries? As the word portrays, boundaries in a relationship help each person establish expectations with their partner. Boundaries can help you communicate what you are comfortable with and what you are willing to […]
© 2025 SimplyWell.ca